Memorial Sloan Kettering Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
- Conditions
- Gastric TumorEsophageal CancerGastroesophageal Junction TumorEsophagogastric TumorsGastric CancerEsophageal NeoplasmsEsophageal TumorGastroEsophageal CancerGastroesophageal Junction AdenocarcinomaGastroesophageal Junction Cancer
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT04510285
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
πΊπΈMemorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
- Conditions
- Breast Cancer
- Interventions
- Other: Ultrasound-guided breast biopsy training programProcedure: US-guided breast biopsy
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 600
- Registration Number
- NCT04501419
- Locations
- π³π¬
Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife, Nigeria
Naxitamab and GM-CSF in People With Neuroblastoma
- Conditions
- High-Risk Neuroblastoma
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT04501757
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of Health-Related Quality of Life in People with Multiple Myeloma Receiving Daratumumab or Lenalidomide
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT04497961
- Locations
- πΊπΈ
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
πΊπΈMemorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Collection of Information to Better Understand Young Onset Colorectal Cancer
- Conditions
- Colorectal CarcinomaColorectal Cancer
- Interventions
- Other: Risk Factor Questionnaire
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 1366
- Registration Number
- NCT04489238
- Locations
- πΊπΈ
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Bergen, Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Communication Training for Cancer Patients, Their Caregivers, and Their Doctors
- Conditions
- Communication and Illness Understanding
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT04479605
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
- Conditions
- Multiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaHDT-AHCT
- Interventions
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 62
- Registration Number
- NCT04478123
- Locations
- πΊπΈ
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
πΊπΈMemorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
πΊπΈMemorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
PREPARE: Patient Centered Perioperative Experience
- Conditions
- Minimally Invasive Surgery (MIS) Hysterectomy
- Interventions
- Other: usual careOther: Educational video
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 275
- Registration Number
- NCT04472117
- Locations
- πΊπΈ
Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre, New York, United States
πΊπΈMemorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
πΊπΈMemorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
- Conditions
- Skin ToxicityGlioblastomaRecurrent Glioblastoma
- Interventions
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 58
- Registration Number
- NCT04469075
- Locations
- πΊπΈ
Northwestern University, Evanston, Illinois, United States
πΊπΈTufts Medical Center, Boston, Massachusetts, United States
πΊπΈWashington University School of Medicine, Saint Louis, Missouri, United States
A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Drug: 89Zr-DFO-daratumumabDiagnostic Test: PET/CT
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2022-07-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT04467281